This research analyzed the effects and mechanism of AURKA on CHOP therapy for the treatment of DLBCL, but deeper mechanism of AURKA on CHOP therapy still needed to be researched and the corresponding treatment was necessary to be developed. This evidence concerns the gene DDIT3 and diffuse large B-cell lymphoma.